These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34860243)

  • 41. Integrated analysis of genome-wide miRNAs and targeted gene expression in esophageal squamous cell carcinoma (ESCC) and relation to prognosis.
    Yang H; Su H; Hu N; Wang C; Wang L; Giffen C; Goldstein AM; Lee MP; Taylor PR
    BMC Cancer; 2020 May; 20(1):388. PubMed ID: 32375686
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inflammatory Breast Carcinoma: Elevated microRNA miR-181b-5p and Reduced miR-200b-3p, miR-200c-3p, and miR-203a-3p Expression as Potential Biomarkers with Diagnostic Value.
    Fahim SA; Abdullah MS; Espinoza-Sánchez NA; Hassan H; Ibrahim AM; Ahmed SH; Shakir G; Badawy MA; Zakhary NI; Greve B; El-Shinawi M; Götte M; Ibrahim SA
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32708601
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroRNA prognostic signature for nodal metastases and survival in esophageal adenocarcinoma.
    Feber A; Xi L; Pennathur A; Gooding WE; Bandla S; Wu M; Luketich JD; Godfrey TE; Litle VR
    Ann Thorac Surg; 2011 May; 91(5):1523-30. PubMed ID: 21420070
    [TBL] [Abstract][Full Text] [Related]  

  • 44. EV-associated miRNAs from peritoneal lavage as potential diagnostic biomarkers in colorectal cancer.
    Roman-Canal B; Tarragona J; Moiola CP; Gatius S; Bonnin S; Ruiz-Miró M; Sierra JE; Rufas M; González E; Porcel JM; Gil-Moreno A; Falcón-Pérez JM; Ponomarenko J; Matias-Guiu X; Colas E
    J Transl Med; 2019 Jun; 17(1):208. PubMed ID: 31221189
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-throughput arrays identify distinct genetic profiles associated with lymph node involvement in rectal cancer.
    Kalady MF; Coffey JC; Dejulius K; Jarrar A; Church JM
    Dis Colon Rectum; 2012 Jun; 55(6):628-39. PubMed ID: 22595841
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of a serum-based miRNA signature for response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy.
    Niwa Y; Yamada S; Sonohara F; Kurimoto K; Hayashi M; Tashiro M; Iwata N; Kanda M; Tanaka C; Kobayashi D; Nakayama G; Koike M; Fujiwara M; Kodera Y
    J Transl Med; 2019 Jan; 17(1):1. PubMed ID: 30602370
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Site-specific associations between miRNA expression and survival in colorectal cancer cases.
    Slattery ML; Herrick JS; Pellatt DF; Mullany LE; Stevens JR; Wolff E; Hoffman MD; Wolff RK; Samowitz W
    Oncotarget; 2016 Sep; 7(37):60193-60205. PubMed ID: 27517623
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exosomal microRNAs as potential biomarkers for cancer cell migration and prognosis in hepatocellular carcinoma patient-derived cell models.
    Yu LX; Zhang BL; Yang Y; Wang MC; Lei GL; Gao Y; Liu H; Xiao CH; Xu JJ; Qin H; Xu XY; Chen ZS; Zhang DD; Li FG; Zhang SG; Liu R
    Oncol Rep; 2019 Jan; 41(1):257-269. PubMed ID: 30542726
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exosomal miRNAs as circulating biomarkers for prediction of development of haematogenous metastasis after surgery for stage II/III gastric cancer.
    Liu X; Chu KM
    J Cell Mol Med; 2020 Jun; 24(11):6220-6232. PubMed ID: 32383554
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma.
    Liu N; Cui RX; Sun Y; Guo R; Mao YP; Tang LL; Jiang W; Liu X; Cheng YK; He QM; Cho WC; Liu LZ; Li L; Ma J
    Int J Cancer; 2014 Mar; 134(6):1359-68. PubMed ID: 23999999
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer.
    Miyoshi J; Toden S; Yoshida K; Toiyama Y; Alberts SR; Kusunoki M; Sinicrope FA; Goel A
    Sci Rep; 2017 Mar; 7():43393. PubMed ID: 28262692
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma Circulating Mirnas Profiling for Identification of Potential Breast Cancer Early Detection Biomarkers.
    Jusoh AR; Mohan SV; Lu Ping T; Tengku Din TADAAB; Haron J; Romli RC; Jaafar H; Nafi SN; Tuan Salwani TI; Yahya MM
    Asian Pac J Cancer Prev; 2021 May; 22(5):1375-1381. PubMed ID: 34048164
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictive Value of Circulating miRNAs in Lymph Node Metastasis for Colon Cancer.
    Lee IH; Kim G; Kwak SG; Baek DW; Kang BW; Kim HJ; Park SY; Park JS; Choi GS; Hur K; Kim JG
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33513887
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aberrant expression of five miRNAs in papillary thyroid carcinomas.
    Qiao DH; He XM; Deng X; Ji YC; Yang H; Cheng L; Zhou XY
    J Clin Lab Anal; 2021 Sep; 35(9):e23907. PubMed ID: 34268792
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Integrated genomic profiling identifies microRNA-92a regulation of IQGAP2 in locally advanced rectal cancer.
    Pelossof R; Chow OS; Fairchild L; Smith JJ; Setty M; Chen CT; Chen Z; Egawa F; Avila K; Leslie CS; Garcia-Aguilar J
    Genes Chromosomes Cancer; 2016 Apr; 55(4):311-321. PubMed ID: 26865277
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An eight-miRNA signature as a potential biomarker for predicting survival in lung adenocarcinoma.
    Li X; Shi Y; Yin Z; Xue X; Zhou B
    J Transl Med; 2014 Jun; 12():159. PubMed ID: 24893932
    [TBL] [Abstract][Full Text] [Related]  

  • 57. miRNAs expression signature potentially associated with lymphatic dissemination in locally advanced prostate cancer.
    Pudova EA; Krasnov GS; Nyushko KM; Kobelyatskaya AA; Savvateeva MV; Poloznikov AA; Dolotkazin DR; Klimina KM; Guvatova ZG; Simanovsky SA; Gladysh NS; Tokarev AT; Melnikova NV; Dmitriev AA; Alekseev BY; Kaprin AD; Kiseleva MV; Snezhkina AV; Kudryavtseva AV
    BMC Med Genomics; 2020 Sep; 13(Suppl 8):129. PubMed ID: 32948204
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity.
    Regev K; Healy BC; Khalid F; Paul A; Chu R; Tauhid S; Tummala S; Diaz-Cruz C; Raheja R; Mazzola MA; von Glehn F; Kivisakk P; Dupuy SL; Kim G; Chitnis T; Weiner HL; Gandhi R; Bakshi R
    JAMA Neurol; 2017 Mar; 74(3):275-285. PubMed ID: 28114622
    [TBL] [Abstract][Full Text] [Related]  

  • 59. miR-129-5p inhibits proliferation, migration, and invasion in rectal adenocarcinoma cells through targeting E2F7.
    Wan P; Bai X; Yang C; He T; Luo L; Wang Y; Fan M; Wang Z; Lu L; Yin Y; Li S; Guo Q; Song Z
    J Cell Physiol; 2020 Jul; 235(7-8):5689-5701. PubMed ID: 32052431
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combination of miRNA and RNA functions as potential biomarkers for gastric cancer.
    Chen S; Zhu J; Yu F; Tian Y; Ma S; Liu X
    Tumour Biol; 2015 Dec; 36(12):9909-18. PubMed ID: 26168960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.